ILIAD BIOTECHNOLOGIES, INC., 2026-02-20
An SEC Form D private-offering notice from Weston, FL, a $115,540,057 filer-stated offering target in Biotech. Filed 2026-02-20. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotech developing BPZE1, a live attenuated intranasal vaccine for pertussis (whooping cough)
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- iCompute AI LLC, 2026-02-23, $4M, Tallahassee, FL
- Lonestar Medicines, Inc., 2026-02-23, $45M, Boston, MA
- Variabl, Inc., 2026-02-23, $3.6M, Boca Raton, FL
- Altesa BioSciences, Inc., 2026-02-23, $75M, College Park, GA
- SIBYL Holdings Corp, 2026-02-23, $1M, Miami, FL
- Inventure, LLC, 2026-02-23, $200K, Southbury, CT
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.